Keywords: عوامل ضد انژیوژنیک; Cancer; Venous thromboembolism; Atrial thromboembolism; Anti-angiogenic agents; Direct oral anticoagulants;
مقالات ISI عوامل ضد انژیوژنیک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: عوامل ضد انژیوژنیک; Targeted therapy; Anti-angiogenic agents; PARP inhibitors; Immunotherapy; Toxicity;
VEGF165b mutant with a prolonged half-life and enhanced anti-tumor potency in a mouse model
Keywords: عوامل ضد انژیوژنیک; Anti-angiogenic agents; Melanoma; Protein expression; Tumor inhibition; Vascular endothelial growth factor 165b;
PARP inhibitors alone and in combination with other biological agents in homologous recombination deficient epithelial ovarian cancer: From the basic research to the clinic
Keywords: عوامل ضد انژیوژنیک; Epithelial ovarian cancer; BRCA; Base excision repair; Homologous recombination deficiency; PARP inhibitors; Anti-angiogenic agents; Immune checkpoint inhibitors;
Cancers bronchiques à petites cellules étendus Traitement standard et nouvelles approches thérapeutiques
Keywords: عوامل ضد انژیوژنیک; Cancer bronchique à petites cellules; Métastases; Chimiothérapie; Anti-angiogènes; Immunothérapie; Small-cell lung cancer; Extensive-stage; Chemotherapy; Anti-angiogenic agents; Immunotherapy;
Inhibition of tumor cell growth and angiogenesis by 7-Aminoalkoxy-4-aryloxy-quinazoline ureas, a novel series of multi-tyrosine kinase inhibitors
Keywords: عوامل ضد انژیوژنیک; VEGFR; PDGFR-ß; c-Kit; Multi-kinase inhibitors; Anti-angiogenic agents; CancerATP, adenosine 5′-triphosphate; DMSO, dimethyl sulfoxide; EGFR, epidermal growth factor receptor; EtOAc, ethyl acetate; FC, flash chromatography; HUVEC, human umbilical vein end
Osteonecrosi dei mascellari associata a bisfosfonati, denosumab e farmaci anti-angiogenetici nei pazienti oncologici e osteoporotici: prevenzione dentale e sicurezza dei trattamenti odontoiatrici
Keywords: عوامل ضد انژیوژنیک; Osteonecrosi; Bisfosfonati; Anti-angiogenetici; Denosumab; Prevenzione odontoiatrica; Osteonecrosis; Bisphosphonates; Anti-angiogenic agents; Denosumab; Dental prevention;
Sequential bevacizumab and oral cyclophosphamide for recurrent ovarian cancer
Keywords: عوامل ضد انژیوژنیک; Ovarian cancer; Anti-angiogenic agents; Bevacizumab; Metronomic therapy
Multitargeted anti-angiogenic agents and NSCLC: Clinical update and future directions
Keywords: عوامل ضد انژیوژنیک; Non-small cell lung cancer (NSCLC); Vascular endothelial growth factor (VEGF); Platelet-derived growth factor (PDGF); Fibroblast growth factor (FGF); Multitargeted kinase inhibitors; Anti-angiogenic agents
The mTOR-targeting drug temsirolimus enhances the growth-inhibiting effects of the cetuximab-bevacizumab-irradiation combination on head and neck cancer xenografts
Keywords: عوامل ضد انژیوژنیک; mTOR inhibitors; Anti-EGFR agents; Anti-angiogenic agents; Head-and-neck cancer; Irradiation;
Antitumor activity of cetuximab associated with the taxotere–cisplatin–fluorouracil (TPF) combination on an orthotopic head and neck cancer model
Keywords: عوامل ضد انژیوژنیک; Docetaxel; Cisplatin; Fluoropyrimidine; Anti-EGFR agents; Anti-angiogenic agents; Head-and-neck cancer
Management of metastatic castration-resistant prostate cancer after first-line docetaxel
Keywords: عوامل ضد انژیوژنیک; Castration-resistant prostate cancer; Docetaxel; Second line; Cytotoxic therapy; Hormonal therapy; Immunotherapy; Anti-angiogenic agents; Clusterin-targeted therapy;
Anti-proliferative and anti-cancer properties of Achyranthes aspera: Specific inhibitory activity against pancreatic cancer cells
Keywords: عوامل ضد انژیوژنیک; Ethno botanicals; Ayurvedic medicine; Traditional medical system (TMS); Real Time PCR; Anti-angiogenic agents; Natural anti-tumor agents
Translating preclinical findings of (endothelial) progenitor cell mobilization into the clinic; from bedside to bench and back
Keywords: عوامل ضد انژیوژنیک; Angiogenesis; Endothelial progenitor cells; Growth factors; Anti-angiogenic agents
Thrombosis associated with angiogenesis inhibitors
Keywords: عوامل ضد انژیوژنیک; angiogenesis; anti-angiogenic agents; cancer; thrombosis; thalidomide; lenalidomide; bavacizumab; sunitinib; sorafenib; semaxibin
Vertical VEGF targeting: A combination of ligand blockade with receptor tyrosine kinase inhibition
Keywords: عوامل ضد انژیوژنیک; Anti-angiogenic agents; Bevacizumab; AZD2171; Drug combination;
Synthesis of N2-(substituted benzyl)-3-(4-methylphenyl)indazoles as novel anti-angiogenic agents
Keywords: عوامل ضد انژیوژنیک; Anti-angiogenic agents; N2-(Substituted benzyl)-3-(4-methylphenyl)-indazoles